tldrdailynews.com logo

Eli Lilly reduces Zepbound weight-loss drug prices amid industry trend

1 min read
Source: CNBC
Eli Lilly reduces Zepbound weight-loss drug prices amid industry trend
Photo: CNBC
TL;DR

Eli Lilly has reduced the cash prices of its Zepbound weight loss drug vials on its direct-to-consumer platform, making the medication more accessible amid industry price cuts and government efforts to lower drug costs. Starting at $299 per month for the initial dose, the prices are now more affordable compared to the previous $349, aiming to improve access for patients facing high list prices and limited insurance coverage.

Topics:top-newsbusiness#business#eli-lilly#pharmaceuticals#price-reduction#weight-loss-drug#zepbound
Share this article
  1. Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site  CNBC
  2. Lilly lowers the price of Zepbound® (tirzepatide) single-dose vials | Eli Lilly and Company  Eli Lilly and Company
  3. Eli Lilly cuts price for popular weight-loss drug Zepbound  USA Today
  4. Weight-Loss Drug Zepbound Cost Drops To $299 A Month After Trump Deal  Forbes
  5. Lilly joins Novo in GLP-1 self-pay price cuts, lowering costs of single-dose Zepbound vials  Fierce Pharma

Want the full story? Read the original reporting

Read on CNBC